All News
Filter News
Found 808,999 articles
-
ADMA Biologics to Report First Quarter 2020 Financial Results on May 6, 2020Conference Call Scheduled for Wednesday, May 6, 2020, at 4:30 p.m. ET
4/29/2020
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and for the prevention of certain infectious diseases, announced that it will report financial results for the first quarter ended March 31, 2020 on Wednesday, May 6, 2020 after the U.S. financial markets close.
-
PPD Extends Digital Clinical Trial Capabilities to Support Biopharma Companies’ Research Continuity and Patient Safety during COVID-19 Pandemic
4/29/2020
PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, has extended its digital clinical trial solutions to support biopharma companies’ research continuity initiatives and to help ensure patient safety as part of its integrated response to the COVID-19 pandemic. PPD’s extensive, flexible suite of digital trial solutions – from electronic patient consent to telehealth to hybrid and fully dece
-
Froedtert & the Medical College of Wisconsin Bolster Resources in Fight Against COVID-19 with Study of Remdesivir
4/29/2020
Froedtert & the Medical College of Wisconsin (MCW) were recently granted enrollment into Gilead Sciences' expanded access program (EAP) to treat COVID-19 patients with the antiviral medication Remdesivir
-
Veeva CRM Now Integrated with Crossix DIFA Marketing Analytics
4/29/2020
Brands will now have complete insight into field and marketing activity to better assess and optimize impact across channels
-
Orchard Therapeutics Announces Eight Presentations Across Gene Therapy Portfolio at the American Society of Gene & Cell Therapy (ASGCT) 23rd Annual Meeting
4/29/2020
Most Comprehensive Presentation of Orchard Clinical Data to Date; Spans Five Disease Areas and Highlights Broad Applicability of Hematopoietic Stem Cell Gene Therapy Approach
-
Cancer Testing and Diagnosis Suffers Sharp Downturn, finds Diaceutics
4/29/2020
Diaceutics PLC, (AIM: DXRX), the precision diagnostic commercialization company, today announces research results from its COVID-19 oncology tracker, which shows the impact of the crisis on cancer testing and diagnosis in the US
-
Precision Spine® Announces the National Launch of the ShurFit® 2C Interbody Systems Featuring Titanium Plasma Spray and Hydroxyapatite Coating
4/29/2020
Precision Spine ® Announces the National Launch of the ShurFit ® 2C Interbody Systems Featuring Titanium Plasma Spray and Hydroxyapatite Coating PARSIPPANY, N.J.--( BUSINESS WIRE )-- Precision Spine, Inc., a medical device company dedicated to Made-in-the-USA manufacturing, has launched nationally the ShurFit ® ACIF 2C Anterior Cervical, TLIF 2C and TPLIF 2C Posterior Interbody Systems, which is made from medical grade polyetheretherketone (Peek Optima,
-
Xeris Extends $0 Copay for Gvoke™ PFS For People With Diabetes Through May 31, 2020
4/29/2020
Xeris Pharmaceuticals, Inc. announced it has extended its $0 copay offer for Gvoke™ Pre-Filled Syringe for commercially eligible patients effective through May 31, 2020 as a response to the COVID-19 pandemic.
-
G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020
4/29/2020
G1 Therapeutics, Inc., a clinical-stage oncology company, announced that it will host a webcast and conference call to provide a corporate and financial update for the first quarter of 2020 on Wednesday, May 6, 2020 at 4:30 p.m. ET.
-
LabCorp Announces 2020 First Quarter Results
4/29/2020
LabCorp announced results for the first quarter ended March 31, 2020.
-
Pharm-Olam Recognized by 2020 CRO Leadership Awards Second Year in a Row
4/29/2020
Pharm-Olam, a leading mid-sized clinical research organization (CRO) serving the pharmaceutical and biotech industry, won multiple recognitions in Life Science Leader magazine’s 2020 CRO Leadership Awards.
-
4D Molecular Therapeutics Announces Upcoming Oral and Poster Presentations at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy
4/29/2020
Oral presentations to include data on 4D-310 Product Candidate for Fabry Disease and 4D-A101 Aerosol Vector for Cystic Fibrosis and other Lung Diseases
-
DiscoveryBioMed and Monell Chemical Senses Center Awarded $1.68 Million Small Business Grant to Profile Bitter Taste Blockers
4/29/2020
Collaboration Will Screen Human Taste Bud Cells with Small Molecule Libraries to Develop Easier Ways for Children and Adults to Take Bitter-Tasting Medications BIRMINGHAM, Ala.--( BUSINESS WIRE )-- DiscoveryBioMed, Inc. (DBM) has been awarded nearly $1.7 million over the next two years by the National Institutes of Health’s Small Business Technology Transfer Research (STTR) program to find bitter taste blockers to improve medication compliance. T
-
Ra Medical Systems Appoints Joan Stafslien to its Board of Directors
4/29/2020
Ra Medical Systems, Inc., a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Joan Stafslien to its Board of Directors, effective April 24, 2020 and expanding Board membership to seven.
-
Blue-Zone Technologies Ltd. Receives Drug Approval From Health Canada for Its Branded Generic DESFLURANE, USP.
4/29/2020
Blue-Zone Technologies Ltd. (“Blue-Zone”) announces receipt from Health Canada of a Drug Identification Number (DIN) for DESFLURANE, USP, an important drug used for general anesthesia.
-
DiscernDx Acquires Luminist Labs to Expand Precision Medicine Solutions for Chronic Diseases
4/29/2020
DiscernDx, today announced the expansion of the company’s precision medicine solutions with the acquisition of Luminist Labs, a privately-held novel diagnostic platform company for the early detection and diagnosis of liver disease.
-
Current Health Launches a Collaboration with Mayo Clinic to Detect COVID-19 Infection Using AI
4/29/2020
Combining Current Health’s remote patient management platform with Mayo Clinic’s medical and scientific expertise, the organizations aim to create AI-driven solutions that aid disease understanding and treatment BOSTON--( BUSINESS WIRE )-- Current Health today announced that it has launched a collaboration with Mayo Clinic to develop remote monitoring solutions that accelerate the identification of COVID-19-positive patients and predict symptom an
-
Veeva to Deliver End-to-End Safety Signal and Risk Management
4/29/2020
Veeva Vault Signal will accelerate signal management processes from detection through risk evaluation and mitigation
-
ProteoGenix Announces a New Human COVID-19 Antibody Library to Accelerate the Discovery of Potent and Urgently Needed Solutions
4/29/2020
ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
-
AACC Launches Free Video Series to Help Explain COVID-19 Testing
4/29/2020
To address some of the confusion surrounding COVID-19 testing, AACC launched a video series in which leading laboratory experts answer common questions about tests for the pandemic.